The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulent M.tb in a ‘challenge’ experiment following vacci...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:F1000Res
Autors principals: Tanner, Rachel, Hoogkamer, Emily, Bitencourt, Julia, White, Andrew, Boot, Charelle, Sombroek, Claudia C., Harris, Stephanie A., O'Shea, Matthew K., Wright, Daniel, Wittenberg, Rachel, Sarfas, Charlotte, Satti, Iman, Verreck, Frank A.W., Sharpe, Sally A., Fletcher, Helen A., McShane, Helen
Format: Artigo
Idioma:Inglês
Publicat: F1000 Research Limited 2021
Matèries:
Method Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097740/
https://ncbi.nlm.nih.gov/pubmed/33976866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.51640.2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars